{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:14:53Z","timestamp":1790727293678,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002668","name":"Bolu Abant \u0130zzet Baysal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clinbiochem.2025.111005","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T14:10:19Z","timestamp":1756649419000},"page":"111005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["How effective is serum FGL1 measurement in assessing disease activity: A cross-sectional study in rheumatoid arthritis"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4168-7809","authenticated-orcid":false,"given":"Mesut","family":"Ates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Ates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujgan","family":"Gurler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Tasci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur Mehmet","family":"Yis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2025.111005_b0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bj.2020.06.010","article-title":"Innate immunity drives pathogenesis of rheumatoid arthritis","volume":"44","author":"Edilova","year":"2021","journal-title":"Biomed J."},{"issue":"62","key":"10.1016\/j.clinbiochem.2025.111005_b0010","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"10","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.clinbiochem.2025.111005_b0015","article-title":"Targeted Deletion of Fibrinogen like Protein 1 reveals a Novel Role in Energy Substrate utilization","volume":"6","author":"Demchev","year":"2013","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.clinbiochem.2025.111005_b0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13045-021-01161-8","article-title":"Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target","volume":"15","author":"Qian","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.clinbiochem.2025.111005_b0025","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bbrc.2007.11.069","article-title":"Fibrinogen-like protein 1, a hepatocyte derived protein is an acute phase reactant","volume":"365","author":"Liu","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.clinbiochem.2025.111005_b0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2018.11.010","article-title":"Fibrinogen-like Protein 1 is a Major Immune Inhibitory Ligand of LAG-3","volume":"176","author":"Wang","year":"2019","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.clinbiochem.2025.111005_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20806","article-title":"FGL1-LAG3 axis impairs IL-10-Producing regulatory T cells associated with Systemic lupus erythematosus disease activity","volume":"9","author":"Chen","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.clinbiochem.2025.111005_b0040","doi-asserted-by":"crossref","DOI":"10.1002\/art.43236","article-title":"FGL1 Modulates Inter\u2010Organ Communication by Controlling T Cell Homeostasis during the Onset of Sj\u00f6gren\u2019s Disease","author":"Otsuka","year":"2025","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.clinbiochem.2025.111005_b0045","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.2147\/JIR.S378953","article-title":"Fibrinogen-like Protein 1 as a Novel Biomarker of Psoriasis Severity","volume":"15","author":"Sun","year":"2022","journal-title":"J. Inflamm. Res."},{"issue":"11","key":"10.1016\/j.clinbiochem.2025.111005_b0050","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s40618-022-01844-0","article-title":"Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case\u2013control study","volume":"45","author":"Zhang","year":"2022","journal-title":"J. Endocrinol. Invest."},{"issue":"13","key":"10.1016\/j.clinbiochem.2025.111005_b0055","doi-asserted-by":"crossref","first-page":"14545","DOI":"10.1080\/21655979.2022.2090379","article-title":"Exosomes derived from fibrinogen-like protein 1-overexpressing bone marrow-derived mesenchymal stem cells ameliorates rheumatoid arthritis","volume":"1","author":"Xu","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.clinbiochem.2025.111005_b0060","first-page":"12","article-title":"Fibrinogen-like Protein 1 Serves as an Anti-Inflammatory Agent for Collagen-Induced Arthritis Therapy in mice","volume":"16","author":"Lin","year":"2021","journal-title":"Front. Immunol."},{"issue":"35","key":"10.1016\/j.clinbiochem.2025.111005_b0065","doi-asserted-by":"crossref","first-page":"247","DOI":"10.46497\/ArchRheumatol.2020.7456","article-title":"Serum C-Reactive Protein\/Albumin Ratio in Rheumatoid Arthritis and its Relationship with disease activity, Physical Function, and Quality of Life","volume":"1","author":"Sunar","year":"2020","journal-title":"Arch Rheumatol."},{"key":"10.1016\/j.clinbiochem.2025.111005_b0070","first-page":"11","article-title":"Fibrinogen-like Protein 1 is a Novel Biomarker for predicting disease activity and Prognosis of Rheumatoid Arthritis","volume":"6","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clinbiochem.2025.111005_b0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.imlet.2017.05.010","article-title":"Biomarkers for rheumatoid arthritis: from molecular processes to diagnostic applications-current concepts and future perspectives","volume":"189","author":"Nakken","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clinbiochem.2025.111005_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2024.100249","article-title":"Unlocking therapeutic potential: Targeting lymphocyte activation Gene-3 (LAG-3) with fibrinogen-like protein 1 (FGL1) in systemic lupus erythematosus","volume":"9","author":"Wang","year":"2024","journal-title":"Journal of Translational Autoimmunity"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:46:04Z","timestamp":1783158364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912025001341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":16,"alternative-id":["S0009912025001341"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111005","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How effective is serum FGL1 measurement in assessing disease activity: A cross-sectional study in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"111005"}}